An open label study on the use of Velcade in combination with high-dose dexamethasone as first line therapy in multiple myeloma patients aged </= 65 years.
Phase of Trial: Phase II
Latest Information Update: 26 May 2011
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 26 May 2011 New trial record